ZBD(SH:603567) Xin Lang Cai Jing·2026-01-13 06:00Group 1 - The core viewpoint of the news is that Zhenbaodao's stock price has experienced fluctuations, with a recent decline of 2.05% and a total market value of 8.977 billion yuan [1] - As of January 13, Zhenbaodao's stock price is reported at 9.54 yuan per share, with a trading volume of 55.8049 million yuan and a turnover rate of 0.62% [1] - The company has seen a net outflow of main funds amounting to 1.4718 million yuan, with large orders accounting for 9.27% of purchases and 11.90% of sales [1] Group 2 - Zhenbaodao's stock price has increased by 6.83% year-to-date, with a 3.58% rise over the last five trading days, but has decreased by 3.15% over the last 20 days and 18.95% over the last 60 days [2] - The company, established on October 28, 1996, and listed on April 24, 2015, specializes in the research, production, and sales of high-end traditional Chinese medicine [2] - The main revenue sources for Zhenbaodao include 84.82% from the sale of proprietary medicines, 7.13% from purchased medicinal materials, and 5.11% from purchased pharmaceuticals [2] Group 3 - As of September 30, the number of shareholders for Zhenbaodao is 20,900, a decrease of 2.72% from the previous period, with an average of 44,969 circulating shares per person, an increase of 2.80% [2] - For the period from January to September 2025, Zhenbaodao reported a revenue of 918 million yuan, a year-on-year decrease of 54.71%, and a net profit attributable to shareholders of -373 million yuan, a year-on-year decrease of 193.81% [2] Group 4 - Zhenbaodao has distributed a total of 1.302 billion yuan in dividends since its A-share listing, with 356 million yuan distributed over the past three years [3]